©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Stem Cells. Jan 26, 2017; 9(1): 9-25
Published online Jan 26, 2017. doi: 10.4252/wjsc.v9.i1.9
Published online Jan 26, 2017. doi: 10.4252/wjsc.v9.i1.9
Optimizing stem cells for cardiac repair: Current status and new frontiers in regenerative cardiology
Shant Der Sarkissian, Nicolas Noiseux, Department of Surgery, Faculté de Médecine, Université de Montréal, Montreal, QC H3C 3J7, Canada
Thierry Lévesque, Faculté de Médecine, Université de Montréal, Montreal, QC H3C 3J7, Canada
Author contributions: All authors contributed to this paper with conception, literature review, editing, references and final approval.
Conflict-of-interest statement: No potential conflicts of interest.
Correspondence to: Nicolas Noiseux, MD, FRCS(C), MSc (Molecular Biology), BSc (Biochemistry), Cardiac Surgeon, Full Professor of Surgery, Director of Research Cardiac Surgery, Department of Surgery, Faculté de Médecine, Université de Montréal, Pavillon Hôtel-Dieu 3840, Saint-Urbain St., Local 2-420, Montreal, QC H3C 3J7, Canada. noiseuxn@videotron.ca
Telephone: +1-514-8908131 Fax: +1-514-4127231
Received: July 1, 2016
Peer-review started: July 3, 2016
First decision: September 5, 2016
Revised: September 29, 2016
Accepted: October 22, 2016
Article in press: October 24, 2016
Published online: January 26, 2017
Processing time: 200 Days and 22.2 Hours
Peer-review started: July 3, 2016
First decision: September 5, 2016
Revised: September 29, 2016
Accepted: October 22, 2016
Article in press: October 24, 2016
Published online: January 26, 2017
Processing time: 200 Days and 22.2 Hours
Core Tip
Core tip: Cell therapy has the potential to improve healing of the ischemic heart, to repopulate injured myocardium and restore cardiac function in ischemic and non-ischemic cardiomyopathy. However, one of the biggest impediments lessening clinical effectiveness of cell therapy is the poor viability, retention and functionality of transplanted cells. This review looks as various stem cell ex vivo preconditioning and reprogramming methods aimed at enhancing the therapeutic potential of stem cells for heart failure treatment.